Loading clinical trials...
Loading clinical trials...
The Effect of Valacyclovir 1g Once Daily on HSV-2 Viral Shedding in Subjects Newly Diagnosed With Genital Herpes Infection
Conditions
Interventions
valacyclovir
Locations
18
United States
GSK Investigational Site
Anaheim, California, United States
GSK Investigational Site
Carmichael, California, United States
GSK Investigational Site
Fair Oaks, California, United States
GSK Investigational Site
Sacramento, California, United States
GSK Investigational Site
San Diego, California, United States
GSK Investigational Site
Boynton Beach, Florida, United States
Start Date
February 20, 2006
Primary Completion Date
November 27, 2006
Completion Date
November 27, 2006
Last Updated
March 23, 2018
NCT02965781
NCT03977792
NCT03310294
NCT03307772
NCT02207881
NCT01985321
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions